SCHEMBL30320501

SCHEMBL30320501

Nc1ccc(-c2nn(-c3ccncc3)c3ncnc(N)c23)cc1F

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 17/20 0.55
▸ EGFR P00533 15/20 0.55
▸ ABL1 P00519 15/20 0.48
▸ PIK3CD O00329 14/20 0.48
▸ HCK P08631 14/20 0.48
▸ KDR P35968 14/20 0.48
▸ PIK3CA P42336 14/20 0.48
▸ PIK3CB P42338 14/20 0.48
▸ MTOR P42345 14/20 0.48
▸ PIK3CG P48736 14/20 0.48
▸ PRKDC P78527 14/20 0.48
▸ EPHB4 P54760 13/20 0.48
▸ PI4KB Q9UBF8 8/20 0.48
▸ RIPK2 O43353 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23997145 1.00 SRC (0.55) SRCEGFRABL1PIK3CDHCK
SCHEMBL27604499 0.82 SRC (0.50) SRCEGFRABL1PIK3CDHCK
SCHEMBL30320603 0.79 PIK3CD (0.65) SRCEGFRABL1PIK3CDHCK
SCHEMBL21436578 0.79 PIK3CD (0.65) SRCEGFRABL1PIK3CDHCK
SCHEMBL5801898 0.77 SRC (0.54) SRCEGFRABL1PIK3CDHCK
SCHEMBL23966926 0.77 RIPK2 (0.56) SRCEGFRABL1KDRRIPK2
SCHEMBL30180934 0.77 RIPK2 (0.56) SRCEGFRABL1KDRRIPK2
SCHEMBL24096509 0.76 SRC (0.79) SRCEGFRABL1PIK3CDHCK
SCHEMBL30320468 0.76 SRC (0.79) SRCEGFRABL1PIK3CDHCK
SCHEMBL23997251 0.76 CYP1A2 (0.69) SRCEGFRABL1PIK3CDHCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116075513-A Inhibitors of NEK7 kinase 哈利亚治疗公司 2023-05-05 — — CN disclosed
EP-4161933-A1 INHIBITORS OF NEK7 KINASE Halia Therapeutics, Inc. (US) 2023-04-12 — — EP disclosed
Send feedback